The Financial and Accounting Team at Akero Therapeutics is responsible for managing the company's financial operations, including budgeting, forecasting, and financial reporting. They ensure compliance with regulatory requirements, oversee the financial planning and analysis (FP&A) for clinical trials, and provide strategic financial insights to support corporate development and the advancement of Akero's lead product candidate, efruxifermin (EFX), in its clinical trials.